Market Executive Summary
Global pharmaceutical contract research organization (CRO) market will reach $45.0 billion by 2030, growing by 9.8% annually over 2021-2030, driven by the increasing incidence of disease, rising healthcare expenditures, increasing dependence on contract research organizations due to improved efficiency and productivity.
Highlighted with 118 tables and 80 figures, this 194-page report ?Global Pharmaceutical Contract Research Organization (CRO) Market 2021-2030 by Service, Therapeutic Application, End User, and Region: Trend Forecast and Growth Opportunity? is based on comprehensive research of the entire global pharmaceutical contract research organization (CRO) market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2030 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
? Market Structure
? Growth Drivers
? Restraints and Challenges
? Emerging Product Trends & Market Opportunities
? Porter?s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global pharmaceutical contract research organization (CRO) market in every aspect of the classification from perspectives of Service, Therapeutic Application, End User, and Region.
Based on Service, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2021-2030 included in each section.
? CRO for Pre-clinical Development
? CRO for Phase I Trials
? CRO for Phase II Trials
? CRO for Phase III Trials
? CRO for Phase IV Trials
? Laboratory Services
? Consulting Services
? Data Management Services
Based on Therapeutic Application, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2021-2030 included in each section.
? Infectious Diseases
? Oncology
? Metabolic Disorders
? Cardiovascular Disorders
? Central Nervous System
? Respiratory Disorders
? Gastrointestinal Disorders
? Other Therapeutic Applications
By End User, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2021-2030 included in each section.
? Pharmaceutical & Biopharmaceutical Companies
? Medical Device Companies
? Academic Institutes
Geographically, the following regions together with the listed national/local markets are fully investigated:
? North America (U.S., Canada, and Mexico)
? Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
? APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
? South America (Brazil, Chile, Argentina, Rest of South America)
? MEA (UAE, Saudi Arabia, South Africa, Other Nations)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ bn) are available for 2021-2030. The breakdown of all regional markets by country and split of key national markets by Service, Therapeutic Application, and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Charles River Laboratories
CMIC Co. Ltd
Covance Inc.
Hangzhou Tigermed Consulting Co., Ltd.
ICON Plc
IQVIA Holdings Inc.
LSK Global Pharma Service Co., Ltd.
Novotech Pty Ltd
PAREXEL International Corporation
Pharmaceutical Product Development LLC (PPD)
PRA Health Sciences Inc.
Quanticate Ltd
Samsung Bioepis Co., Ltd.
SGS SA (SGS Life Sciences)
Syneos Health Inc.
WuXi AppTec Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Table of Contents
1 Introduction 9
1.1 Industry Definition and Research Scope 9
1.1.1 Industry Definition 9
1.1.2 Research Scope 10
1.2 Research Methodology 13
1.2.1 Overview of Market Research Methodology 13
1.2.2 Market Assumption 14
1.2.3 Secondary Data 14
1.2.4 Primary Data 14
1.2.5 Data Filtration and Model Design 16
1.2.6 Market Size/Share Estimation 17
1.2.7 Research Limitations 18
1.3 Executive Summary 19
2 Market Overview and Dynamics 22
2.1 Market Size and Forecast 22
2.1.1 Impact of COVID-19 on World Economy 23
2.1.2 Impact of COVID-19 on the Market 25
2.2 Major Growth Drivers 27
2.3 Market Restraints and Challenges 35
2.4 Emerging Opportunities and Market Trends 38
2.5 Porter?s Fiver Forces Analysis 42
3 Segmentation of Global Market by Service 46
3.1 Market Overview by Service 46
3.2 CRO for Pre-clinical Development 48
3.3 CRO for Phase I Trials 49
3.4 CRO for Phase II Trials 50
3.5 CRO for Phase III Trials 51
3.6 CRO for Phase IV Trials 52
3.7 Laboratory Services 53
3.8 Consulting Services 54
3.9 Data Management Services 55
4 Segmentation of Global Market by Therapeutic Application 56
4.1 Market Overview by Therapeutic Application 56
4.2 Infectious Diseases 58
4.3 Oncology 59
4.4 Metabolic Disorders 60
4.5 Cardiovascular Disorders 61
4.6 Central Nervous System 62
4.7 Respiratory Disorders 63
4.8 Gastrointestinal Disorders 64
4.9 Other Therapeutic Applications 65
5 Segmentation of Global Market by End User 66
5.1 Market Overview by End User 66
5.2 Pharmaceutical & Biopharmaceutical Companies 68
5.3 Medical Device Companies 69
5.4 Academic Institutes 70
6 Segmentation of Global Market by Region 71
6.1 Geographic Market Overview 2019-2030 71
6.2 North America Market 2019-2030 by Country 75
6.2.1 Overview of North America Market 75
6.2.2 U.S. 79
6.2.3 Canada 82
6.2.4 Mexico 84
6.3 European Market 2019-2030 by Country 86
6.3.1 Overview of European Market 86
6.3.2 Germany 90
6.3.3 UK 92
6.3.4 France 94
6.3.5 Spain 96
6.3.6 Italy 98
6.3.7 Russia 100
6.3.8 Rest of European Market 102
6.4 Asia-Pacific Market 2019-2030 by Country 104
6.4.1 Overview of Asia-Pacific Market 104
6.4.2 Japan 108
6.4.3 China 111
6.4.4 Australia 113
6.4.5 India 115
6.4.6 South Korea 117
6.4.7 Rest of APAC Region 119
6.5 South America Market 2019-2030 by Country 121
6.5.1 Argentina 124
6.5.2 Brazil 126
6.5.3 Chile 128
6.5.4 Rest of South America Market 130
6.6 MEA Market 2019-2030 by Country 131
6.6.1 UAE 134
6.6.2 Saudi Arabia 136
6.6.3 South Africa 138
6.6.4 Other National Markets 140
7 Competitive Landscape 141
7.1 Overview of Key Vendors 141
7.2 New Product Launch, Partnership, Investment, and M&A 145
7.3 Company Profiles 146
Charles River Laboratories 146
CMIC Co. Ltd 148
Covance Inc. 150
Hangzhou Tigermed Consulting Co., Ltd. 154
ICON Plc 157
IQVIA Holdings Inc. 160
LSK Global Pharma Service Co., Ltd. 164
Novotech Pty Ltd 166
PAREXEL International Corporation 168
Pharmaceutical Product Development LLC (PPD) 172
PRA Health Sciences Inc. 174
Quanticate Ltd 176
Samsung Bioepis Co., Ltd. 178
SGS SA (SGS Life Sciences) 180
Syneos Health Inc. 183
WuXi AppTec Inc. 186
8 Investing in Global Market: Risk Assessment and Management 188
8.1 Risk Evaluation of Global Market 188
8.2 Critical Success Factors (CSFs) 191
Related Reports and Products 194
List of Figures
List of Figures:
Figure 1. Research Method Flow Chart 13
Figure 2. Breakdown of Primary Research 15
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 17
Figure 4. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2030 19
Figure 5. Global Pharmaceutical CRO Market, 2019-2030, $ bn 22
Figure 6. Impact of COVID-19 on Business 25
Figure 7. Primary Drivers and Impact Factors of Global Pharmaceutical CRO Market 27
Figure 8. Leading Causes of Death in the World, 2019-2020, million 32
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 33
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060 33
Figure 11. Primary Restraints and Impact Factors of Global Pharmaceutical CRO Market 35
Figure 12. Investment Opportunity Analysis 39
Figure 13. Porter?s Fiver Forces Analysis of Global Pharmaceutical CRO Market 42
Figure 14. Breakdown of Global Pharmaceutical CRO Market by Service, 2019-2030, % of Sales Revenue 47
Figure 15. Global Addressable Market Cap in 2022-2030 by Service, Value ($ bn) and Share (%) 47
Figure 16. Global Pharmaceutical CRO Market: CRO for Pre-clinical Development, 2019-2030, $ bn 48
Figure 17. Global Pharmaceutical CRO Market: CRO for Phase I Trials, 2019-2030, $ bn 49
Figure 18. Global Pharmaceutical CRO Market: CRO for Phase II Trials, 2019-2030, $ bn 50
Figure 19. Global Pharmaceutical CRO Market: CRO for Phase III Trials, 2019-2030, $ bn 51
Figure 20. Global Pharmaceutical CRO Market: CRO for Phase IV Trials, 2019-2030, $ bn 52
Figure 21. Global Pharmaceutical CRO Market: Laboratory Services, 2019-2030, $ bn 53
Figure 22. Global Pharmaceutical CRO Market: Consulting Services, 2019-2030, $ bn 54
Figure 23. Global Pharmaceutical CRO Market: Data Management Services, 2019-2030, $ bn 55
Figure 24. Breakdown of Global Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, % of Sales Revenue 57
Figure 25. Global Addressable Market Cap in 2022-2030 by Therapeutic Application, Value ($ bn) and Share (%) 57
Figure 26. Global Pharmaceutical CRO Market: Infectious Diseases, 2019-2030, $ bn 58
Figure 27. Global Pharmaceutical CRO Market: Oncology, 2019-2030, $ bn 59
Figure 28. Global Pharmaceutical CRO Market: Metabolic Disorders, 2019-2030, $ bn 60
Figure 29. Global Pharmaceutical CRO Market: Cardiovascular Disorders, 2019-2030, $ bn 61
Figure 30. Global Pharmaceutical CRO Market: Central Nervous System, 2019-2030, $ bn 62
Figure 31. Global Pharmaceutical CRO Market: Respiratory Disorders, 2019-2030, $ bn 63
Figure 32. Global Pharmaceutical CRO Market: Gastrointestinal Disorders, 2019-2030, $ bn 64
Figure 33. Global Pharmaceutical CRO Market: Other Therapeutic Applications, 2019-2030, $ bn 65
Figure 34. Breakdown of Global Pharmaceutical CRO Market by End User, 2019-2030, % of Revenue 67
Figure 35. Global Addressable Market Cap in 2022-2030 by End User, Value ($ bn) and Share (%) 67
Figure 36. Global Pharmaceutical CRO Market: Pharmaceutical & Biopharmaceutical Companies, 2019-2030, $ bn 68
Figure 37. Global Pharmaceutical CRO Market: Medical Device Companies, 2019-2030, $ bn 69
Figure 38. Global Pharmaceutical CRO Market: Academic Institutes, 2019-2030, $ bn 70
Figure 39. Global Market Snapshot by Region 71
Figure 40. Geographic Spread of Worldwide Pharmaceutical CRO Market, 2019-2030, % of Sales Revenue 72
Figure 41. Global Addressable Market Cap in 2022-2030 by Region, Value ($ bn) and Share (%) 73
Figure 42. North American Pharmaceutical CRO Market, 2019-2030, $ bn 76
Figure 43. Breakdown of North America Pharmaceutical CRO Market by Country, 2021 and 2030, % of Revenue 77
Figure 44. Contribution to North America 2022-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%) 78
Figure 45. U.S. Pharmaceutical CRO Market, 2019-2030, $ bn 80
Figure 46. Canada Pharmaceutical CRO Market, 2019-2030, $ bn 82
Figure 47. Pharmaceutical CRO Market in Mexico, 2015-2030, $ bn 84
Figure 48. European Pharmaceutical CRO Market, 2019-2030, $ bn 87
Figure 49. Breakdown of European Pharmaceutical CRO Market by Country, 2021 and 2030, % of Revenue 88
Figure 50. Contribution to Europe 2022-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%) 89
Figure 51. Pharmaceutical CRO Market in Germany, 2019-2030, $ bn 90
Figure 52. Pharmaceutical CRO Market in UK, 2019-2030, $ bn 92
Figure 53. Pharmaceutical CRO Market in France, 2019-2030, $ bn 94
Figure 54. Pharmaceutical CRO Market in Spain, 2019-2030, $ bn 96
Figure 55. Pharmaceutical CRO Market in Italy, 2019-2030, $ bn 98
Figure 56. Pharmaceutical CRO Market in Russia, 2019-2030, $ bn 100
Figure 57. Pharmaceutical CRO Market in Rest of Europe, 2019-2030, $ bn 102
Figure 58. Asia-Pacific Pharmaceutical CRO Market, 2019-2030, $ bn 105
Figure 59. Breakdown of APAC Pharmaceutical CRO Market by Country, 2021 and 2030, % of Revenue 105
Figure 60. Contribution to APAC 2022-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%) 107
Figure 61. Pharmaceutical CRO Market in Japan, 2019-2030, $ bn 109
Figure 62. Pharmaceutical CRO Market in China, 2019-2030, $ bn 111
Figure 63. Pharmaceutical CRO Market in Australia, 2019-2030, $ bn 113
Figure 64. Pharmaceutical CRO Market in India, 2019-2030, $ bn 115
Figure 65. Pharmaceutical CRO Market in South Korea, 2019-2030, $ bn 117
Figure 66. Pharmaceutical CRO Market in Rest of APAC, 2019-2030, $ bn 119
Figure 67. South America Pharmaceutical CRO Market, 2019-2030, $ bn 122
Figure 68. Breakdown of South America Pharmaceutical CRO Market by Country, 2021 and 2030, % of Revenue 122
Figure 69. Contribution to South America 2022-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%) 123
Figure 70. Pharmaceutical CRO Market in Argentina, 2019-2030, $ bn 124
Figure 71. Pharmaceutical CRO Market in Brazil, 2019-2030, $ bn 126
Figure 72. Pharmaceutical CRO Market in Chile, 2019-2030, $ bn 128
Figure 73. Pharmaceutical CRO Market in Rest of South America, 2019-2030, $ bn 130
Figure 74. Pharmaceutical CRO Market in MEA, 2019-2030, $ bn 132
Figure 75. Breakdown of MEA Pharmaceutical CRO Market by Country, 2021 and 2030, % of Revenue 132
Figure 76. Contribution to MEA 2022-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%) 133
Figure 77. Pharmaceutical CRO Market in UAE, 2019-2030, $ bn 134
Figure 78. Pharmaceutical CRO Market in Saudi Arabia, 2019-2030, $ bn 136
Figure 79. Pharmaceutical CRO Market in South Africa, 2019-2030, $ bn 138
Figure 80. Growth Stage of Global Pharmaceutical CRO Industry over the Forecast Period 141
This report focuses on:
► Intelligent insights to take informed business decisions.
► Qualitative and quantitative analysis of the market.
► Market size and forecasts from 2024 to 2030.
► Opportunities for expansion and in-depth market analysis.
► Segmentation and regional revenue forecasts.
► Analysis of the market share and competitive landscape.
► Strategic recommendations for future growth.
You'll also receive:
► A comprehensive market research report in PDF or PPT formats.
► Access to our analysts to learn more about the report and get answers to your specific business questions.
► The option to customize the report to meet your specific needs, such as adding more countries or regions or developing abusiness case to launch a new product.
Contact us today to learn more and get sample report.
Our Research Reports Look Like This
